CATHAY INTERNATIONAL HOLDINGS LIMITED 
By Notification of Annual Results - London Stock Exchange
Page 1 of 2
Regulatory Story
Go to market news section
CompanyCathay International Holdings Ld
TIDM CTI
Headline Notification of Annual Results
Released 10:00 19-Mar-2012
Number 5872Z10
RNS Number : 5872Z
Cathay International Holdings
Ld
19 March 2012
Cathay International Holdings
Limited
Notification of Annual
Results
Hong Kong, 19 March
2012 - Cathay
International Holdings
Limited ("Cathay"
or "the
Company") (LSE:
CTI.L), an investment
holding company and
leading investor in
the growing healthcare
sector in the
People's Republic
of China, today
announces that it
will issue its
Annual Results for
the year ended
31 December 2011
on Thursday 29
March
2012.
-Ends- For further
enquiries, please
contact:
Cathay International Holdings
Limited
Eric Siu (Finance
Director)
Patrick Sung (Director
and Controller)
Tel: +852 2828
9289
M:Communications
Mary-Jane Elliott/ Amber
Bielecka / Claire
Dickinson
Tel: +44 (0) 207
920 2330
About Cathay
Cathay International Holdings
Limited (CTI.L),
focused on the
People's Republic
of China
("PRC"), is
an investment holding
company and a
leading investor in
the growing healthcare
sector in China.
The Group employs
more than 2,000
people across the
PRC, including over
30 specialist
corporate and business
development staff
based at the
holding company's
headquarters in Hong
Kong and Shenzhen.
Cathay aims to
identify investment
opportunities with
emphasis on high
http://www.londonstockexchange.com/exchange/news/market-news/market-news-detai...
3/19/2012
Notification of Annual Results - London Stock Exchange
Page 2 of 2
growth healthcare markets
and build them
into market sector
leaders, with a
clear exit strategy.
Cathay has
demonstrated a strong
track record of
identifying high-growth
potential investment
opportunities in this
area including: Lansen
Group, a leading
specialty pharmaceutical
company focused on
rheumatology and
Haotian Group, a
company engaged in
the manufacture,
marketing and sale
of key active
ingredients for
healthcare products,
including inositol. To
complement its
healthcare portfolio,
Cathay has an
R&D business focused
on bringing new
products to the
growing Chinese
market.
Cathay also has a
private equity
investment arm focused
on minority investment
opportunities and a
hotel investment.
The Company's website
is at http://www.cathay-intl.com.hk
This information is
provided by RNS
The company news
service from the
London Stock
Exchange
END
NORDMGMFLLFGZZG
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Termsandconditions, including restrictions on use and distribution apply.
©2009 London Stock Exchange plc. All rights reserved
Regulatory
http://www.londonstockexchange.com/exchange/news/market-news/market-news-detai...
3/19/2012
|
distributed by
| This press release was issued by Cathay International Holdings Ltd. and was initially posted at http://www.cathay-intl.com.hk/newsItem/view.action;jsessionid=05A100FAFF4DD6EF8A73EC924C7614EE?from= notice&eid=rir42f5j . It was distributed, unedited and unaltered, by noodls on 2012-03-19 12:49:43 PM. The issuer is solely responsible for the accuracy of the information contained therein. |
